HEADER NUCLEAR PROTEIN 23-OCT-22 8BF2 TITLE HUMAN PPARGAMMA IN COMPLEX WITH MEHP BOUND TO THE AF-2 AND OMEGA SUB- TITLE 2 POCKETS COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS PPAR GAMMA ACTIVATION, LIGAND BINDING DOMAIN, MEHP, ENVIRONMENTAL KEYWDS 2 CONTAMINANT, NUCLEAR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.USEINI,N.STRAETER REVDAT 2 07-FEB-24 8BF2 1 REMARK REVDAT 1 08-MAR-23 8BF2 0 JRNL AUTH A.USEINI,F.ENGELBERGER,G.KUNZE,N.STRATER JRNL TITL STRUCTURAL BASIS OF THE ACTIVATION OF PPAR GAMMA BY THE JRNL TITL 2 PLASTICIZER METABOLITES MEHP AND MINCH. JRNL REF ENVIRON INT V. 173 07822 2023 JRNL REFN ISSN 1873-6750 JRNL PMID 36841188 JRNL DOI 10.1016/J.ENVINT.2023.107822 REMARK 2 REMARK 2 RESOLUTION. 2.18 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.18 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.08 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 33671 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1718 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.0800 - 4.9900 0.99 2757 168 0.1880 0.2251 REMARK 3 2 4.9900 - 3.9600 0.99 2703 149 0.1732 0.1955 REMARK 3 3 3.9600 - 3.4600 1.00 2718 134 0.1915 0.2382 REMARK 3 4 3.4600 - 3.1500 0.99 2717 136 0.2274 0.2966 REMARK 3 5 3.1500 - 2.9200 1.00 2705 130 0.2393 0.2560 REMARK 3 6 2.9200 - 2.7500 0.99 2701 146 0.2229 0.2703 REMARK 3 7 2.7500 - 2.6100 0.99 2680 156 0.2401 0.2617 REMARK 3 8 2.6100 - 2.5000 0.99 2679 150 0.2441 0.2974 REMARK 3 9 2.5000 - 2.4000 0.99 2669 143 0.2475 0.3523 REMARK 3 10 2.4000 - 2.3200 1.00 2693 149 0.2565 0.3100 REMARK 3 11 2.3200 - 2.2500 0.99 2661 141 0.2877 0.3369 REMARK 3 12 2.2500 - 2.1800 0.84 2270 116 0.3312 0.3774 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.288 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.431 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.78 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4319 REMARK 3 ANGLE : 0.429 5813 REMARK 3 CHIRALITY : 0.035 672 REMARK 3 PLANARITY : 0.002 754 REMARK 3 DIHEDRAL : 11.813 1673 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8BF2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1292126170. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JAN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91840 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : DIALS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33690 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.180 REMARK 200 RESOLUTION RANGE LOW (A) : 48.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.18 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 6DHA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS PH, 7.6 0.8 M SODIUM REMARK 280 CITRATE, PH 7.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 292.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.73000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.76150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.73000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.76150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 195 REMARK 465 ARG A 196 REMARK 465 GLY A 197 REMARK 465 SER A 198 REMARK 465 HIS A 199 REMARK 465 HIS A 200 REMARK 465 HIS A 201 REMARK 465 HIS A 202 REMARK 465 HIS A 203 REMARK 465 HIS A 204 REMARK 465 GLY A 205 REMARK 465 PRO A 206 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 MET B 195 REMARK 465 ARG B 196 REMARK 465 GLY B 197 REMARK 465 SER B 198 REMARK 465 HIS B 199 REMARK 465 HIS B 200 REMARK 465 HIS B 201 REMARK 465 HIS B 202 REMARK 465 HIS B 203 REMARK 465 HIS B 204 REMARK 465 GLY B 205 REMARK 465 PRO B 206 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 LYS B 275 REMARK 465 ASP B 462 REMARK 465 MET B 463 REMARK 465 LEU B 478 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 628 O HOH B 668 2.14 REMARK 500 O HOH A 652 O HOH A 659 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS B 244 145.96 -172.02 REMARK 500 ARG B 357 152.12 -42.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 707 DISTANCE = 5.84 ANGSTROMS DBREF 8BF2 A 206 477 UNP P37231 PPARG_HUMAN 234 505 DBREF 8BF2 B 206 479 UNP P37231 PPARG_HUMAN 234 505 SEQADV 8BF2 MET A 195 UNP P37231 INITIATING METHIONINE SEQADV 8BF2 ARG A 196 UNP P37231 EXPRESSION TAG SEQADV 8BF2 GLY A 197 UNP P37231 EXPRESSION TAG SEQADV 8BF2 SER A 198 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS A 199 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS A 200 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS A 201 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS A 202 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS A 203 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS A 204 UNP P37231 EXPRESSION TAG SEQADV 8BF2 GLY A 205 UNP P37231 EXPRESSION TAG SEQADV 8BF2 MET B 195 UNP P37231 INITIATING METHIONINE SEQADV 8BF2 ARG B 196 UNP P37231 EXPRESSION TAG SEQADV 8BF2 GLY B 197 UNP P37231 EXPRESSION TAG SEQADV 8BF2 SER B 198 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS B 199 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS B 200 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS B 201 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS B 202 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS B 203 UNP P37231 EXPRESSION TAG SEQADV 8BF2 HIS B 204 UNP P37231 EXPRESSION TAG SEQADV 8BF2 GLY B 205 UNP P37231 EXPRESSION TAG SEQRES 1 A 283 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY PRO GLU SEQRES 2 A 283 SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR ASP SEQRES 3 A 283 SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS ALA SEQRES 4 A 283 ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SER PRO SEQRES 5 A 283 PHE VAL ILE TYR ASP MET ASN SER LEU MET MET GLY GLU SEQRES 6 A 283 ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN GLU SEQRES 7 A 283 GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY CYS SEQRES 8 A 283 GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR GLU SEQRES 9 A 283 TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP LEU SEQRES 10 A 283 ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU SEQRES 11 A 283 ILE ILE TYR THR MET LEU ALA SER LEU MET ASN LYS ASP SEQRES 12 A 283 GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR ARG SEQRES 13 A 283 GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP PHE SEQRES 14 A 283 MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA SEQRES 15 A 283 LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE ALA SEQRES 16 A 283 VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU ASN SEQRES 17 A 283 VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU GLN SEQRES 18 A 283 ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU SER SEQRES 19 A 283 SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR ASP SEQRES 20 A 283 LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU GLN SEQRES 21 A 283 VAL ILE LYS LYS THR GLU THR ASP MET SER LEU HIS PRO SEQRES 22 A 283 LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 B 283 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY PRO GLU SEQRES 2 B 283 SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR ASP SEQRES 3 B 283 SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS ALA SEQRES 4 B 283 ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SER PRO SEQRES 5 B 283 PHE VAL ILE TYR ASP MET ASN SER LEU MET MET GLY GLU SEQRES 6 B 283 ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN GLU SEQRES 7 B 283 GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY CYS SEQRES 8 B 283 GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR GLU SEQRES 9 B 283 TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP LEU SEQRES 10 B 283 ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU SEQRES 11 B 283 ILE ILE TYR THR MET LEU ALA SER LEU MET ASN LYS ASP SEQRES 12 B 283 GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR ARG SEQRES 13 B 283 GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP PHE SEQRES 14 B 283 MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA SEQRES 15 B 283 LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE ALA SEQRES 16 B 283 VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU ASN SEQRES 17 B 283 VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU GLN SEQRES 18 B 283 ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU SER SEQRES 19 B 283 SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR ASP SEQRES 20 B 283 LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU GLN SEQRES 21 B 283 VAL ILE LYS LYS THR GLU THR ASP MET SER LEU HIS PRO SEQRES 22 B 283 LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR HET QGL A 501 42 HET QGL A 502 42 HET QGL B 501 42 HETNAM QGL 2-[(2~{S})-2-ETHYLHEXOXY]CARBONYLBENZOIC ACID HETSYN QGL MEHP FORMUL 3 QGL 3(C16 H22 O4) FORMUL 6 HOH *184(H2 O) HELIX 1 AA1 GLU A 207 PHE A 226 1 20 HELIX 2 AA2 THR A 229 GLY A 239 1 11 HELIX 3 AA3 ASP A 251 ILE A 262 1 12 HELIX 4 AA4 GLU A 276 ILE A 303 1 28 HELIX 5 AA5 ASP A 310 ALA A 331 1 22 HELIX 6 AA6 SER A 342 GLY A 344 5 3 HELIX 7 AA7 ARG A 350 SER A 355 1 6 HELIX 8 AA8 MET A 364 ASN A 375 1 12 HELIX 9 AA9 ALA A 376 GLU A 378 5 3 HELIX 10 AB1 ASP A 380 LEU A 393 1 14 HELIX 11 AB2 ASN A 402 HIS A 425 1 24 HELIX 12 AB3 GLN A 430 GLU A 460 1 31 HELIX 13 AB4 HIS A 466 LYS A 474 1 9 HELIX 14 AB5 SER B 208 PHE B 226 1 19 HELIX 15 AB6 THR B 229 GLY B 239 1 11 HELIX 16 AB7 ASP B 251 LYS B 263 1 13 HELIX 17 AB8 VAL B 277 ILE B 303 1 27 HELIX 18 AB9 ASP B 310 ALA B 331 1 22 HELIX 19 AC1 SER B 342 GLY B 344 5 3 HELIX 20 AC2 ARG B 350 SER B 355 1 6 HELIX 21 AC3 MET B 364 ALA B 376 1 13 HELIX 22 AC4 ASP B 380 LEU B 393 1 14 HELIX 23 AC5 ASN B 402 HIS B 425 1 24 HELIX 24 AC6 GLN B 430 GLU B 460 1 31 HELIX 25 AC7 HIS B 466 TYR B 473 1 8 SHEET 1 AA1 4 PHE A 247 ILE A 249 0 SHEET 2 AA1 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 AA1 4 GLY A 338 ILE A 341 -1 N ILE A 341 O GLY A 346 SHEET 4 AA1 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 AA2 4 PHE B 247 ILE B 249 0 SHEET 2 AA2 4 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 AA2 4 GLY B 338 ILE B 341 -1 N VAL B 339 O MET B 348 SHEET 4 AA2 4 MET B 334 ASN B 335 -1 N ASN B 335 O GLY B 338 CRYST1 93.460 61.523 118.245 90.00 102.64 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010700 0.000000 0.002399 0.00000 SCALE2 0.000000 0.016254 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008667 0.00000